Infinity Pharma (INFI) Posts Mixed Q2 Results

Infinity Pharma (NASDAQ: INFI) reported Q2 EPS of $1.05, $1.94 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $13.91 million.

For earnings history and earnings-related data on Infinity Pharma (INFI) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
• Mercury Systems (MRCY) Misses Q4 EPS by 2c